GARONIT PHARMACEUTICAL, INC. – Trademark Portfolio
Entity Type: 03
GARONIT PHARMACEUTICAL, INC. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 2 are pending. Notable registered marks include TFN, PREPSAFE, BACTOPREP, MICROPREP, and G GARONIT PHARMACEUTICAL. The owner is based in FAIRFIELD, NJ.
10A MADISON ROAD, SUITE A
FAIRFIELD, NJ 07004
Showing of trademarks Trademarks
Trademark Classifications
GARONIT PHARMACEUTICAL, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does GARONIT PHARMACEUTICAL, INC. have?
GARONIT PHARMACEUTICAL, INC. has 8 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 pending.
What trademark classes does GARONIT PHARMACEUTICAL, INC. file in?
GARONIT PHARMACEUTICAL, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are GARONIT PHARMACEUTICAL, INC.'s most well-known trademarks?
GARONIT PHARMACEUTICAL, INC.'s registered trademark portfolio includes well-known marks such as TFN, PREPSAFE, BACTOPREP, MICROPREP, and G GARONIT PHARMACEUTICAL. These are among 6 currently registered trademarks in the portfolio.
What is GARONIT PHARMACEUTICAL, INC.'s trademark registration success rate?
GARONIT PHARMACEUTICAL, INC. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 2 applications are pending review.